{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:59:24Z","timestamp":1781294364567,"version":"3.54.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Sarcomatoid dedifferentiated melanoma (SDDM) represents a diagnostic challenge as this cutaneous spindle cell melanoma lacks expression of classic melanocytic markers including S100, SOX10, Melan-A, HMB45, and MITF. The expression of the emerging melanoma marker preferentially expressed antigen in melanoma (PRAME) in SDDM is largely unknown. In this article, a case of SDDM arising in association with a nodular melanoma is highlighted. A 65-year-old man presented with a several week history of an ulcerated lesion on the right medial knee. A shave biopsy of the lesion revealed a biphasic neoplasm, which consisted of a centrally located poorly differentiated spindle cell component and an adjacent nodular component consisting of atypical melanocytes arranged in nests and fascicles. While the nodular component stained for S100, SOX10, and Melan-A, the spindle cell component failed to stain for these conventional melanocytic markers, only staining diffusely for CD10 and faintly for CD68. Both components stained for PRAME diffusely albeit less intensely within the spindle cell component. Next-generation DNA sequencing assay of the microdissected biphasic components revealed a shared mutation of NRAS. The results of the PRAME immunohistochemical stain and next-generation DNA sequencing assay facilitated in establishing the diagnosis of SDDM in association with nodular melanoma.<\/jats:p>","DOI":"10.1097\/dad.0000000000002092","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:09:19Z","timestamp":1635858559000},"page":"282-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing"],"prefix":"10.1097","volume":"44","author":[{"given":"Alexander A.","family":"Valiga","sequence":"first","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin G.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Thomas Jefferson University Hospital, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Pennsylvania Dermatology Partners, Bensalem, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/PAS.0000000000000201","article-title":"Desmoplastic melanoma with sarcomatoid dedifferentiation","volume":"38","author":"Kiuru","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/DAD.0000000000000716","article-title":"Living on the edge: diagnosing sarcomatoid melanoma using histopathologic cues at the edge of a dedifferentiated tumor: a report of 2 cases and review of the literature","volume":"39","author":"Erstine","year":"2017","journal-title":"Am J Dermatopathol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cup.13646","article-title":"CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: a cautionary (and molecularly annotated) tale","volume":"47","author":"Lefferts","year":"2020","journal-title":"J Cutan Pathol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PAS.0000000000001645","article-title":"Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/cup.14003","article-title":"Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma","volume":"48","author":"Chung","year":"2021","journal-title":"J Cutan Pathol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"102060","DOI":"10.1016\/j.ctrv.2020.102060","article-title":"Dedifferentiated melanomas: morpho-phenotypic profile, genetic reprogramming and clinical implications","volume":"88","author":"Massi","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/DAD.0000000000001626","article-title":"SOX-10 and S100 negative desmoplastic melanoma: apropos a diagnostically challenging case","volume":"42","author":"Kooper-Johnson","year":"2020","journal-title":"Am J Dermatopathol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.bjoms.2020.09.007","article-title":"Pleomorphic dermal sarcoma: a clinical and histological review of 49 cases","volume":"59","author":"Bowe","year":"2021","journal-title":"Br J Oral Maxillofac Surg."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1440-0960.2005.00190.x","article-title":"Atypical fibroxanthoma: a clinicopathological study of 89 cases","volume":"46","author":"Mirza","year":"2005","journal-title":"Australas J Dermatol."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/DAD.0000000000000993","article-title":"Diagnosis of sarcomatoid melanoma by surrogate immunostains","volume":"40","author":"Fraga","year":"2018","journal-title":"Am J Dermatopathol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/PAS.0000000000001492","article-title":"Comparison of immunohistochemistry for PRAME with cytogenetic test results in the evaluation of challenging melanocytic tumors","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/PAS.0000000000000451","article-title":"NF1 mutations are common in desmoplastic melanoma","volume":"39","author":"Wiesner","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CMR.0000000000000628","article-title":"Frequency of mutations in BRAF, NRAS, and KIT in different populations and histological subtypes of melanoma: a systemic review","volume":"30","author":"Guti\u00e9rrez-Casta\u00f1eda","year":"2020","journal-title":"Melanoma Res."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.2013.168","article-title":"TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod Pathol."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"dju246","DOI":"10.1093\/jnci\/dju246","article-title":"TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma","volume":"106","author":"Griewank","year":"2014","journal-title":"J Natl Cancer Inst."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen","year":"2011","journal-title":"Haematologica"},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.6004\/jnccn.2016.0161","article-title":"A polycythemia vera JAK2 mutation masquerading as a duodenal cancer mutation","volume":"14","author":"Lee","year":"2016","journal-title":"J Natl Compr Canc Netw."},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1002\/cncr.31345","article-title":"Melanoma: what do all the mutations mean?","volume":"124","author":"Davis","year":"2018","journal-title":"Cancer"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:01:14Z","timestamp":1750100474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002092","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,2]]}}}